Why Obesity-Drug Makers Just Lost Weight

Market heard on the street Novo Nordisk and Eli Lilly working to increase capacity, insurance coverage

Eli Lilly Earnings Show 9% Sales Drop on Covid-19 Treatment Decline

Business revenue Strong dollar, low realized prices also weigh on top line

FDA Rejects Lilly’s Alzheimer’s Drug Candidate, Seeks More Data

Business Health care Health The setback could delay the potential commercial introduction of a drug called…

FDA Pulls Lilly’s Covid Antibody Drug

Health The drug bebtelovimab is no longer expected to neutralize the common Omicron subvariant BQ. 1…

Newest Alzheimer’s Drugs Take Large But Fraught Step Toward Approval

Positive study results for Eisai-Biogen lifted prospects for its drug and one from Eli Lilly —…

Elon Musk, Bernie Sanders and Others Miss the Mark Over Pricey Insulin

Markets Heard on the Street Big Pharma has taken much of the heat for sky-high insulin…

Lack of Optimism for Alzheimer’s Trials Means There’s Little to Lose

Companies seeking a treatment for Alzheimer’s disease have spent an astonishing amount of money in recent…

WSJ News Exclusive | U.S. Plans to Shift Bill for Covid Shots and Treatments to Insurers, Patients

The Biden administration is planning for an end to its practice of paying for Covid-19 shots…

Eli Lilly Speaks Out Against Indiana’s Ban on Most Abortions

Eli Lilly & Co. spoke out against Indiana’s new abortion law, saying the restrictions could hurt…

New Weight-Loss Drugs Can Fatten Drugmakers’ Profits

Obesity kills millions every year, yet drug companies and doctors have mainly focused on treating diseases…